dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Calleja, José Luis |
dc.contributor.author | Rivera Esteban, Jesus Manuel |
dc.contributor.author | Aller, Rocío |
dc.contributor.author | Abad, Javier |
dc.contributor.author | Pericàs Pulido, Juan Manuel |
dc.contributor.author | Hernandez Conde, Marta |
dc.contributor.author | Augustin Recio, Salvador |
dc.date.accessioned | 2022-10-11T09:45:28Z |
dc.date.available | 2022-10-11T09:45:28Z |
dc.date.issued | 2022-08 |
dc.identifier.citation | Calleja JL, Rivera-Esteban J, Aller R, Hernández-Conde M, Abad J, Pericàs JM, et al. Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology. Liver Int. 2022 Aug;42(8):1783–92. |
dc.identifier.issn | 1478-3231 |
dc.identifier.uri | https://hdl.handle.net/11351/8287 |
dc.description | Fibrosi hepàtica; Esteatohepatitis no alcohòlica; Elastografia transitòria |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Liver International;42(8) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Esteatosi hepàtica - Epidemiologia |
dc.subject | Fetge - Fibrosi - Imatgeria |
dc.subject | Esteatosi hepàtica - Imatgeria |
dc.subject.mesh | Non-alcoholic Fatty Liver Disease |
dc.subject.mesh | Elasticity Imaging Techniques |
dc.subject.mesh | Prevalence |
dc.title | Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1111/liv.15323 |
dc.subject.decs | esteatosis hepática no alcohólica |
dc.subject.decs | elastografía |
dc.subject.decs | prevalencia |
dc.relation.publishversion | https://doi.org/10.1111/liv.15323 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Calleja JL, Hernández-Conde M, Abad J] Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro, School of Medicine, Universidad Autónoma Madrid, IDIPHIM, Majadahonda, Spain. [Rivera-Esteban J] Unitat Hepàtica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Aller R] Department of Gastroenterology, Clinic University Hospital, Medical School, Group of Biomedical Research in Critical Care Medicine (BioCritic), University of Valladolid, Valladolid, Spain. Research Unit, Clinic University Hospital, Medical School, Institute of Health Sciences of Castille and Leon (IECSCYL), Group of Biomedical Research in Critical Care Medicine (BioCritic), Valladolid, Spain. [Pericàs JM] Unitat Hepàtica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Augustin S] Unitat Hepàtica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Therapeutic Area Cardio-Metabolism and Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany |
dc.identifier.pmid | 35643936 |
dc.identifier.wos | 000807259900001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |